Eosinophil Granulocytes Account for Indoleamine 2,3-Dioxygenase-Mediated Immune Escape in Human Non Small Cell Lung Cancer

Indoleamine 2,3-dioxygenase (IDO), a catabolizing enzyme of tryptophan, is supposed to play a role in tumor immune escape. Its expression in solid tumors has not yet been well elucidated: IDO can be expressed by the tumor cells themselves, or by ill-defined infiltrating cells, possibly depending on...

Full description

Bibliographic Details
Main Authors: Simonetta Astigiano, Barbara Morandi, Roberta Costa, Luca Mastracci, Antonella D'Agostino, Giovanni Battista Ratto, Giovanni Melioli, Guido Frumento
Format: Article
Language:English
Published: Elsevier 2005-04-01
Series:Neoplasia: An International Journal for Oncology Research
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S1476558605800703
_version_ 1818938744888098816
author Simonetta Astigiano
Barbara Morandi
Roberta Costa
Luca Mastracci
Antonella D'Agostino
Giovanni Battista Ratto
Giovanni Melioli
Guido Frumento
author_facet Simonetta Astigiano
Barbara Morandi
Roberta Costa
Luca Mastracci
Antonella D'Agostino
Giovanni Battista Ratto
Giovanni Melioli
Guido Frumento
author_sort Simonetta Astigiano
collection DOAJ
description Indoleamine 2,3-dioxygenase (IDO), a catabolizing enzyme of tryptophan, is supposed to play a role in tumor immune escape. Its expression in solid tumors has not yet been well elucidated: IDO can be expressed by the tumor cells themselves, or by ill-defined infiltrating cells, possibly depending on tumor type. We have investigated IDO expression in 25 cases of non small cell lung cancer (NSCLC). Using histochemistry and immunohistochemistry, we found that IDO was expressed not by tumor cells, but by normal cells infiltrating the peritumoral stroma. These cells were neither macrophages nor dendritic cells, and were identified as eosinophil granulocytes. The amount of IDO-positive eosinophils varied in different cases, ranging from a few cells to more than 50 per field at x200 magnification. IDO protein in NSCLC was enzymatically active. Therefore, at least in NSCLC cases displaying a large amount of these cells in the inflammatory infiltrate, IDO-positive eosinophils could exert an effective immunosuppressive action. On analyzing the 17 patients with adequate follow-up, a significant relationship was found between the amount of IDO-positive infiltrate and overall survival. This finding suggests that the degree of IDO-positive infiltrate could be a prognostic marker in NSCLC.
first_indexed 2024-12-20T06:12:44Z
format Article
id doaj.art-12599b9b5b1c44258e48d440e9a7f6dd
institution Directory Open Access Journal
issn 1476-5586
1522-8002
language English
last_indexed 2024-12-20T06:12:44Z
publishDate 2005-04-01
publisher Elsevier
record_format Article
series Neoplasia: An International Journal for Oncology Research
spelling doaj.art-12599b9b5b1c44258e48d440e9a7f6dd2022-12-21T19:50:37ZengElsevierNeoplasia: An International Journal for Oncology Research1476-55861522-80022005-04-017439039610.1593/neo.04658Eosinophil Granulocytes Account for Indoleamine 2,3-Dioxygenase-Mediated Immune Escape in Human Non Small Cell Lung CancerSimonetta Astigiano0Barbara Morandi1Roberta Costa2Luca Mastracci3Antonella D'Agostino4Giovanni Battista Ratto5Giovanni Melioli6Guido Frumento7Istituto Nazionale per la Ricerca sul Cancro, Genoa, ItalyIstituto Nazionale per la Ricerca sul Cancro, Genoa, ItalyChirurgia Toracica, Ospedale S. Antonio e Biagio e Cesare Arrigo, Alessandria, ItalyDICMI, Università di Genova, Genoa, ItalyLaboratori Centrali, Istituto G. Gaslini, Genoa, ItalyChirurgia Toracica, Ospedale S. Croce e Carle, Cuneo, ItalyLaboratori Centrali, Istituto G. Gaslini, Genoa, ItalyIstituto Nazionale per la Ricerca sul Cancro, Genoa, ItalyIndoleamine 2,3-dioxygenase (IDO), a catabolizing enzyme of tryptophan, is supposed to play a role in tumor immune escape. Its expression in solid tumors has not yet been well elucidated: IDO can be expressed by the tumor cells themselves, or by ill-defined infiltrating cells, possibly depending on tumor type. We have investigated IDO expression in 25 cases of non small cell lung cancer (NSCLC). Using histochemistry and immunohistochemistry, we found that IDO was expressed not by tumor cells, but by normal cells infiltrating the peritumoral stroma. These cells were neither macrophages nor dendritic cells, and were identified as eosinophil granulocytes. The amount of IDO-positive eosinophils varied in different cases, ranging from a few cells to more than 50 per field at x200 magnification. IDO protein in NSCLC was enzymatically active. Therefore, at least in NSCLC cases displaying a large amount of these cells in the inflammatory infiltrate, IDO-positive eosinophils could exert an effective immunosuppressive action. On analyzing the 17 patients with adequate follow-up, a significant relationship was found between the amount of IDO-positive infiltrate and overall survival. This finding suggests that the degree of IDO-positive infiltrate could be a prognostic marker in NSCLC.http://www.sciencedirect.com/science/article/pii/S1476558605800703Non small cell lung cancerindoleamine 2,3-dioxygenaseeosinophil granulocytesimmune escapeprognostic marker
spellingShingle Simonetta Astigiano
Barbara Morandi
Roberta Costa
Luca Mastracci
Antonella D'Agostino
Giovanni Battista Ratto
Giovanni Melioli
Guido Frumento
Eosinophil Granulocytes Account for Indoleamine 2,3-Dioxygenase-Mediated Immune Escape in Human Non Small Cell Lung Cancer
Neoplasia: An International Journal for Oncology Research
Non small cell lung cancer
indoleamine 2,3-dioxygenase
eosinophil granulocytes
immune escape
prognostic marker
title Eosinophil Granulocytes Account for Indoleamine 2,3-Dioxygenase-Mediated Immune Escape in Human Non Small Cell Lung Cancer
title_full Eosinophil Granulocytes Account for Indoleamine 2,3-Dioxygenase-Mediated Immune Escape in Human Non Small Cell Lung Cancer
title_fullStr Eosinophil Granulocytes Account for Indoleamine 2,3-Dioxygenase-Mediated Immune Escape in Human Non Small Cell Lung Cancer
title_full_unstemmed Eosinophil Granulocytes Account for Indoleamine 2,3-Dioxygenase-Mediated Immune Escape in Human Non Small Cell Lung Cancer
title_short Eosinophil Granulocytes Account for Indoleamine 2,3-Dioxygenase-Mediated Immune Escape in Human Non Small Cell Lung Cancer
title_sort eosinophil granulocytes account for indoleamine 2 3 dioxygenase mediated immune escape in human non small cell lung cancer
topic Non small cell lung cancer
indoleamine 2,3-dioxygenase
eosinophil granulocytes
immune escape
prognostic marker
url http://www.sciencedirect.com/science/article/pii/S1476558605800703
work_keys_str_mv AT simonettaastigiano eosinophilgranulocytesaccountforindoleamine23dioxygenasemediatedimmuneescapeinhumannonsmallcelllungcancer
AT barbaramorandi eosinophilgranulocytesaccountforindoleamine23dioxygenasemediatedimmuneescapeinhumannonsmallcelllungcancer
AT robertacosta eosinophilgranulocytesaccountforindoleamine23dioxygenasemediatedimmuneescapeinhumannonsmallcelllungcancer
AT lucamastracci eosinophilgranulocytesaccountforindoleamine23dioxygenasemediatedimmuneescapeinhumannonsmallcelllungcancer
AT antonelladagostino eosinophilgranulocytesaccountforindoleamine23dioxygenasemediatedimmuneescapeinhumannonsmallcelllungcancer
AT giovannibattistaratto eosinophilgranulocytesaccountforindoleamine23dioxygenasemediatedimmuneescapeinhumannonsmallcelllungcancer
AT giovannimelioli eosinophilgranulocytesaccountforindoleamine23dioxygenasemediatedimmuneescapeinhumannonsmallcelllungcancer
AT guidofrumento eosinophilgranulocytesaccountforindoleamine23dioxygenasemediatedimmuneescapeinhumannonsmallcelllungcancer